These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9234543)

  • 1. Protective immunity induced by rotavirus DNA vaccines.
    Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
    Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines against rotavirus infections.
    Herrmann JE; Chen SC; Fynan EF; Santoro JC; Greenberg HB; Robinson HL
    Arch Virol Suppl; 1996; 12():207-15. PubMed ID: 9015117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Knowlton DR; McNeal MM; Ward RL
    Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
    Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
    Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against rotavirus infections by DNA vaccination.
    Herrmann JE; Chen SC; Fynan EF; Santoro JC; Greenberg HB; Wang S; Robinson HL
    J Infect Dis; 1996 Sep; 174 Suppl 1():S93-7. PubMed ID: 8752297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity obtained by gene-gun inoculation of a rotavirus DNA vaccine to the abdominal epidermis or anorectal epithelium.
    Chen SC; Fynan EF; Greenberg HB; Herrmann JE
    Vaccine; 1999 Aug; 17(23-24):3171-6. PubMed ID: 10462253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
    Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE
    Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
    Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
    Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.
    Chen SC; Jones DH; Fynan EF; Farrar GH; Clegg JC; Greenberg HB; Herrmann JE
    J Virol; 1998 Jul; 72(7):5757-61. PubMed ID: 9621034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization.
    Lopez-Guerrero DV; Arias N; Gutierrez-Xicotencatl L; Chihu-Amparan L; González A; Pedroza-Saavedra A; Rosas-Salgado G; Villegas-Garcia JC; Badillo-Godinez O; Fernandez G; Lopez S; Esquivel-Guadarrama F
    Vaccine; 2018 May; 36(22):3072-3078. PubMed ID: 28465094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
    Feng N; Lawton JA; Gilbert J; Kuklin N; Vo P; Prasad BV; Greenberg HB
    J Clin Invest; 2002 May; 109(9):1203-13. PubMed ID: 11994409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
    Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
    J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus virus-like particles administered mucosally induce protective immunity.
    O'Neal CM; Crawford SE; Estes MK; Conner ME
    J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.
    Burns JW; Siadat-Pajouh M; Krishnaney AA; Greenberg HB
    Science; 1996 Apr; 272(5258):104-7. PubMed ID: 8600516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
    Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
    Yuan L; Azevedo MS; Gonzalez AM; Jeong KI; Van Nguyen T; Lewis P; Iosef C; Herrmann JE; Saif LJ
    Vaccine; 2005 Jun; 23(30):3925-36. PubMed ID: 15917114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.